Induction infliximab levels among patients with acute severe ulcerative colitis compared with patients with moderately severe ulcerative colitis-Reference-Cited by-同舟云学术

Induction infliximab levels among patients with acute severe ulcerative colitis compared with patients with moderately severe ulcerative colitis

Published:2016-04-19 Issue:12 Volume:43 Page:1293-1299
ISSN:0269-2813
Container-title:Alimentary Pharmacology & Therapeutics
language:en
Short-container-title:Aliment Pharmacol Ther

Author:

Ungar B.¹,Mazor Y.²,Weisshof R.²,Yanai H.³,Ron Y.³,Goren I.³,Waizbard A.³,Yavzori M.¹,Fudim E.¹,Picard O.¹,Loebstein R.⁴,Kopylov U.¹,Dotan I.³,Chowers Y.²,Eliakim R.¹,Ben-Horin S.¹

Affiliation:

1. Department of Gastroenterology; Sheba Medical Center & Sackler School of Medicine; Tel-Aviv University; Tel Hashomer Israel

2. Rambam Health Care Campus & Bruce Rappaport School of Medicine; Technion Institute of Technology; Haifa Israel

3. IBD Center; Department of Gastroenterology; Tel-Aviv Sourasky Medical Center & Sackler School of Medicine; Tel-Aviv University; Israel

4. Institute of Clinical Pharmacology; Sheba Medical Center & Sackler School of Medicine; Tel-Aviv University; Tel Hashomer Israel

Funder

The Chaim Sheba Medical Center

Sheba Medical Center

Rambam Health Care Center

Leona M. and Harry B. Helmsley Charitable Trust

Publisher

Wiley

Subject

Pharmacology (medical),Gastroenterology,Hepatology

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1111/apt.13631/fullpdf

Reference30 articles.

1. The pattern and outcome of acute severe colitis;Dinesen;J Crohns Colitis,2010

2. Intravenous cyclosporine versus intravenous corticosteroids as single therapy for severe attacks of ulcerative colitis;D'Haens;Gastroenterology,2001

3. Mortality in patients with and without colectomy admitted to hospital for ulcerative colitis and Crohn's disease: record linkage studies;Roberts;BMJ,2007

4. Randomised controlled trial. Comparison Of iNfliximab and ciclosporin in STeroid Resistant Ulcerative Colitis: trial design and protocol (CONSTRUCT);Seagrove;BMJ Open,2014

5. Ciclosporin versus infliximab in patients with severe ulcerative colitis refractory to intravenous steroids: a parallel, open-label randomised controlled trial;Laharie;Lancet,2012

Cited by 78 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Infliximab in Inflammatory Bowel Disease: Leveraging Physiologically Based Pharmacokinetic Modeling in the Clinical Context;Biomedicines;2024-09-01

2. What are the benefits of therapeutic drug monitoring in the optimization of adalimumab therapy? a systematic review and meta-analysis up to 2022;Frontiers in Pharmacology;2024-07-08

3. Monitorización terapéutica de los fármacos biológicos en la enfermedad inflamatoria intestinal. Documento de Posicionamiento del Grupo Español de Trabajo en Enfermedad de Crohn y Colitis Ulcerosa (GETECCU);Gastroenterología y Hepatología;2024-05

4. Therapeutic drug monitoring in inflammatory bowel diseases. Position statement of the Spanish Working Group on Crohn’s Disease and Ulcerative Colitis;Gastroenterología y Hepatología (English Edition);2024-05

5. Acute severe ulcerative colitis management: unanswered questions and latest insights;The Lancet Gastroenterology & Hepatology;2024-03